{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:28:15Z","timestamp":1761236895791},"reference-count":36,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The efficacy of passive immunization as a postexposure prophylactic measure for treatment of guinea pigs intranasally infected with\n            <jats:italic>Bacillus anthracis<\/jats:italic>\n            spores was evaluated. Antisera directed either against the lethal toxin components (PA or LF) or against a toxinogenic strain (Sterne) were used for this evaluation. All antisera exhibited high enzyme-linked immunosorbent assay titers against the corresponding antigens, high titers of neutralization of cytotoxicity activity in an in vitro mouse macrophages cell line (J774A.1), as well as in vivo neutralization of toxicity when administered either directly to Fisher rats prior to challenge with the lethal toxin or after incubation with the lethal toxin. In these tests, anti-LF antiserum exhibited the highest neutralization efficiency, followed by anti-Sterne and anti-PA. The time dependence and antibody dose necessary for conferring postexposure protection by the various antibodies of guinea pigs infected with 25 50% lethal doses of Vollum spores was examined. Rabbit anti-PA serum was found to be the most effective. Intraperitoneal injections of anti-PA serum given 24 h postinfection protected 90% of the infected animals, whereas anti-Sterne and anti-LF were less effective. These results further emphasizes the importance of anti-PA antibodies in conferring protection against\n            <jats:italic>B. anthracis<\/jats:italic>\n            infection and demonstrated the ability of such antibodies to be effectively applied as an efficient postexposure treatment against anthrax disease.\n          <\/jats:p>","DOI":"10.1128\/iai.70.2.544-550.2002","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:55:53Z","timestamp":1027763753000},"page":"544-560","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":88,"title":["Efficiency of Protection of Guinea Pigs against Infection with\n            <i>Bacillus anthracis<\/i>\n            Spores by Passive Immunization"],"prefix":"10.1128","volume":"70","author":[{"given":"David","family":"Kobiler","sequence":"first","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehoshua","family":"Gozes","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagai","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"Marcus","sequence":"additional","affiliation":[{"name":"Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaul","family":"Reuveny","sequence":"additional","affiliation":[{"name":"Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeev","family":"Altboum","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.83.6.1274-1280.1962"},{"key":"e_1_3_2_3_2","first-page":"144","volume":"35","year":"1954","unstructured":"Belton, F. C., and R. E. Strange. 1954. Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. 1954. Br. J. Exp. Pathol.35:144\u2013152.","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_3_2_4_2","first-page":"6","volume":"72","year":"1960","unstructured":"Brachman, P. S., S. A. Plotkin, F. H. Bumford, and M. M. Atchison. 1960. An epidemic of inhalation anthrax: the first in the twentieth century. Am. J. Hyg.72:6\u201323.","journal-title":"Am. J. Hyg."},{"key":"e_1_3_2_5_2","first-page":"306","volume":"340","year":"1992","unstructured":"Bradaric, N., and V. Punda-Polic. 1992. Cutaneous anthrax due to penicillin\u2013resistant Bacillus anthracis transferred by an insect bite. Lancet340:306\u2013307.","journal-title":"Lancet"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.8.4549-4558.2000"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.45.3.761-767.1984"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.2.349-356.1988"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)38364-3"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.5.1239"},{"key":"e_1_3_2_11_2","first-page":"394","volume":"27","year":"1946","unstructured":"Gladston, G. P. 1946. Immunity to anthrax: protective antigen present in cell-free culture filtrates. Br. J. Exp. Pathol.27:394\u2013418.","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.49.2.291-297.1985"},{"key":"e_1_3_2_13_2","first-page":"105","volume":"13","year":"1990","unstructured":"Hambleton, P., and P. C. B. Turnbull. 1990. Anthrax vaccine development: a continuing story. Adv. Biotechnol. Processes13:105\u2013122.","journal-title":"Adv. Biotechnol. Processes"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.21.10198"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.3.11.1269"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(89)90397-9"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.85.2.451-460.1963"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400044272"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)80112-6"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/151.2.71"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(88)65019-1"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Leppla S. H. B. E. Ivins and J. W. Ezzell. 1985. Anthrax toxin p. 63\u201366. In L. Levine (ed.) Microbiology\u20141985. ASM Press Washington D.C.","DOI":"10.21236\/ADA148936"},{"key":"e_1_3_2_23_2","first-page":"327","volume":"9","year":"1964","unstructured":"Lincoln, R. E., J. S. Walker, F. Klein, and B. W. Haines. 1964. Anthrax. Adv. Vet. Sci.9:327\u2013368.","journal-title":"Anthrax. Adv. Vet. Sci."},{"key":"e_1_3_2_24_2","first-page":"759","volume":"4","year":"1965","unstructured":"Lincoln R.E. F. Klein, J. S. Walker, B. W. Haines, W. I. Jones, B. G. Mahlandt, and R. H. Friedman. 1965. Successful treatment of rhesus monkey for septicemic anthrax. Antimicrob. Agents Chemother.4:759\u2013763.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.6.1606-1613.1990"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.12.5171-5175.1997"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7973702"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.39.1.371-376.1983"},{"key":"e_1_3_2_29_2","first-page":"153","year":"1956","unstructured":"Presoneus, G. M. S. Cooper, and R. C. Pervical. 1956. Studies on an anthrax vaccine prepared from nonencapsulated variants of Bacillus anthracis. Am. J. Vet. Res.153\u2013156.","journal-title":"Am. J. Vet. Res."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/am.11.4.330-334.1963"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.2888-2893.2001"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.39.1.483-486.1983"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700730219"},{"key":"e_1_3_2_34_2","first-page":"307","volume":"13","year":"1939","unstructured":"Sterne, M. 1939. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J. Vet. Sci. Anim. Industry 13:307\u2013312.","journal-title":"J. Vet. Sci. Anim."},{"key":"e_1_3_2_35_2","first-page":"293","volume":"177","year":"1988","unstructured":"Turnbull, P. C. B., S. H. Leppla, M. G. Broster, C. P. Quinnand, and J. Melling. 1988. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med. Microbiol. Immunol.177:293\u2013303.","journal-title":"Med. Microbiol. Immunol."},{"key":"e_1_3_2_36_2","first-page":"363","volume":"131","year":"1985","unstructured":"Uchida, I., T. Sekizaki, K. Hashimoto, and N. Terakado. 1985. Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid. J. Gen. Microbiol.131:363\u2013367.","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_37_2","unstructured":"Wilson G. S. and A. Miles (ed.). 1952. Anthrax p. 1954. In Topley and Wilson\u2019s principles of bacteriology and immunity 4th ed. Edward Arnold Publishers Ltd. London England."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.2.544-550.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.2.544-550.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:38:21Z","timestamp":1646447901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.70.2.544-550.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1128\/IAI.70.2.544-550.2002"],"URL":"https:\/\/doi.org\/10.1128\/iai.70.2.544-550.2002","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"type":"print","value":"0019-9567"},{"type":"electronic","value":"1098-5522"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"2001-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-11-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}